New guidance manual for addressing viral hepatitis in people with substance use disorders

'Addressing Viral Hepatitis in People With Substance Use Disorders' is a new manual developed to provide behavioral health care programs offering substance abuse treatment services information to better address the needs of clients who have viral hepatitis. The manual was developed by the Substance Abuse and Mental Health Services Administration (SAMHSA).

The manual is one of the latest in the Treatment Improvement Protocol (TIP) series. TIPs are best-practice guidelines developed by SAMHSA to help provide state-of-the-art information to behavioral health care providers about effective treatment approaches.

This TIP is organized into two parts:

• Part 1. Addressing Viral Hepatitis in People With Substance Use Disorders
• Part 2. Addressing Viral Hepatitis in People With Substance Use Disorders: A Review of the Literature

Part 1 is for counselors and administrators of behavioral health programs providing substance abuse treatment. It comprises seven chapters and emphasizes steps substance abuse treatment counselors and administrators can take to educate clients, prevent new hepatitis infections, and help clients who have viral hepatitis recover from their substance use disorders. Information is provided at a basic level so that it can be understood by readers without medical training.

Part 2 is an online literature review for clinical supervisors, program administrators, and counselors interested in reviewing the medical literature on which this TIP is based. The literature review, is available and will be updated every 6 months for 5 years following publication of this TIP.

TIP 53: Addressing Viral Hepatitis in People With Substance Use Disorders is available here. Printed copies may be obtained free of charge by contacting SAMHSA’s Health Information Network by ordering online at or by calling at 1-877-SAMHSA-7 (1-877-726-4727). Request inventory number (SMA) 11-4656. For related publications and information, please visit SAMHSA.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.